Skip to main content

Chemotherapy of Advanced Gastric Carcinoma in Elderly and High-Risk Patients

  • Conference paper
Gastric Carcinoma
  • 53 Accesses

Abstract

Gastric carcinoma is the second leading cause of death in cases of malignant neoplasias in the Federal Republic of Germany. A total of 28 of 100,000 inhabitants die from gastric carcinoma every year.1

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Statistisches Bundesamt Wiesbaden: Gesundheitswesen, Fachserie 12 Todesursachen 1983. Statistisches Bundesamt. Wiesbaden, W. Kohlhammer, Stuttgart, 1984, p 12.

    Google Scholar 

  2. Waterhouse JAH: Epidemiology of gastric cancer, in Preece PE, Cuschieri A, Wellwood JM (eds): Cancer of the Stomach. London, Grune & Stratton, 1985, p 1.

    Google Scholar 

  3. Hunter CP, Frelick RW, Feldman AR, et al: Selection factors in clinical trials: results from the community clinical oncology program physician’s patient log. Cancer Treat Rep 1987; 71: 559.

    PubMed  CAS  Google Scholar 

  4. Lee YJ, Catane R, Rozencweig M, et al: Analysis and interpretation of response rates for anticancer drugs. Cancer Treat Rep 1970; 63: 1713.

    Google Scholar 

  5. Walder S, Green M, Muggia F: The role of anthracyclines in the treatment of gastric cancer. Cancer Treat Rev 1985; 12: 105.

    Article  Google Scholar 

  6. Queisser W, Flechtner H: Chemotherapy of advanced gastric carcinoma. Onkologie 1986; 9: 319.

    Article  PubMed  CAS  Google Scholar 

  7. DeSimone PA, Gams R, Birch R: Phase II evaluation of mitoxantrone in advanced carcinoma of the stomach: a Southwestern Cancer Study Group trial. Cancer Treat Rep 1986; 70: 1043.

    PubMed  CAS  Google Scholar 

  8. Louie AC, Issell BF: Amsacrine (AMSA) - a clinical review. J Clin Oncol 1985; 3: 562.

    PubMed  CAS  Google Scholar 

  9. Aisner J, Van Echo DA, Whitacre J, et al: A phase I trial of continuous infusion VP16–213 (Etoposide). Cancer Chemother Pharmacol 1982; 7: 157.

    PubMed  CAS  Google Scholar 

  10. Greco FA, Johnson DH, Hande RK, et al: High-dose etoposide (VP-16) in small-cell lung cancer. Sem Oncol 1985; 12 (suppl 2): 42.

    CAS  Google Scholar 

  11. Kelsen DP, Magill G, Cheng E, et al: Phase II trial of etoposide (VP16) in the treatment of upper gastrointestinal malignancies, abstract. Proc ASCO 1982;96:C-371.

    Google Scholar 

  12. Seeber S, Osieka R, Schmidt CG, et al: In vivo resistance towards anthracyclines, etoposide, and cis-diaminedichloroplatinum (II). Cancer Res 1982; 67: 4719.

    Google Scholar 

  13. Tozak LK, Von Hoff DD: The cardiotoxicity of anticancer agents, in Perry MC, Yabro JW (eds): Toxicity of Chemotherapy. Orlando, Grune & Stratton, 1984, p 199.

    Google Scholar 

  14. Franke H: Wesen and Bedeutung der Polypathie and Multimorbidität in der Alterscheilkunde. Internist 1984; 25: 451.

    PubMed  CAS  Google Scholar 

  15. Lipschitz DA: Conference: cancer in the elderly: basic science and clinical aspects. Ann Intern Med 1985; 102: 218.

    PubMed  CAS  Google Scholar 

  16. Vestal RE: Drug use in the elderly: a review of problems and special considerations. Drugs 1978; 16: 358.

    Article  PubMed  CAS  Google Scholar 

  17. Gallmeier WM: Krebstherapie im Alter. Mun Med Wochens 1977; 43: 1379.

    Google Scholar 

  18. Douglass HO, Trave F, Milliron S, et al: A phase II trial of 5-fluorouracil and high-dose intravenous leukovorin in gastric carcinoma. J Clin Oncol 1987; 5: 1150.

    PubMed  Google Scholar 

  19. Machover D, Goldschmidt E, Chollet P: Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid. J Clin Oncol 1986; 4: 685.

    PubMed  CAS  Google Scholar 

  20. Hill BT: Potential of continuous tumor cell lines for establishing patterns of cross-resistance and collateral sensitivity in vitro. Drugs Exp Clin Res 1986; 12: 293.

    PubMed  CAS  Google Scholar 

  21. Osswald H, Kunz W: Therapeutic synergism of etoposide and fluorouracil combined sequentially in advanced leukemia L1210, abstract. Cancer Res Clin Oncol 1987; 113(suppl): 53; 39.

    Google Scholar 

  22. World Health Organization: Handbook for Reporting Results of Cancer Treatment. WHO Offset Publication No. 48. World Health Organization, 1979, p 1.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag New York, Inc.

About this paper

Cite this paper

Preusser, P., Wilke, H., Achterrath, W., Fink, U. (1989). Chemotherapy of Advanced Gastric Carcinoma in Elderly and High-Risk Patients. In: Hotz, J., Meyer, HJ., Schmoll, HJ. (eds) Gastric Carcinoma. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-3636-8_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-3636-8_15

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-96955-8

  • Online ISBN: 978-1-4612-3636-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics